Target intelligence / Profile preview

Novel transcript, antisense to MAPKAP1 (ENSG00000287782)

Target
ENSG00000287782
Molecular classification
Other (long non-coding RNA)
01

Overview

Novel transcript, antisense to MAPKAP1 (ENSG00000287782) is a long non-coding RNA gene that is transcribed from the antisense strand near the protein-coding MAPKAP1 gene on chromosome 9. It is classified as lncRNA and does not encode a protein. Its biological function, disease roles, and interactions are not documented in current public genomic resources. Being antisense to MAPKAP1, it may share genomic context or regulatory interplay with MAPKAP1, but no direct function has been established. The presence of this transcript as an overlapping intronic variant with MAPKAP1 is noted, but its functional relevance has not been described in major genomic databases. If therapeutic target information for MAPKAP1 is needed (e.g., as part of the mTORC2 complex), the focus should shift to MAPKAP1 protein, not to this noncoding antisense transcript. Long non-coding RNAs such as this are commonly annotated in genome databases but typically do not act as direct drug targets. This transcript should be distinguished from protein-coding therapeutic targets and is not standard in drug development, disease biomarker, or molecular classification schemes for targets.

Other names
Novel transcript, antisense to MAPKAP1ENSG00000287782HSALNG0074399
02

Mechanism of action

None

03

Biological functions

Unknown
04

Disease associations

Unknown

Beyond the preview

Go deeper on Novel transcript, antisense to MAPKAP1 (ENSG00000287782).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to MAPKAP1 (ENSG00000287782).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call